| scholarly article | Q13442814 |
| P2093 | author name string | Robert MacPhail | |
| Eric Grulke | |||
| Robert Yokel | |||
| P2860 | cites work | Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO2 nanoparticles | Q42943532 |
| Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells | Q42948890 | ||
| Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. | Q43067199 | ||
| Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles | Q43098424 | ||
| Size-dependent tissue kinetics of PEG-coated gold nanoparticles | Q43145893 | ||
| Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity | Q43239219 | ||
| Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity | Q43270729 | ||
| Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines | Q43738911 | ||
| Accuracy of calculated pH-dependent aqueous drug solubility. | Q44986945 | ||
| Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye. | Q45988593 | ||
| Probing the Cytotoxicity Of Semiconductor Quantum Dots | Q46112957 | ||
| Partial oxidation ("aging") and surface modification decrease the toxicity of nanosized zerovalent iron | Q46125526 | ||
| Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases | Q46257909 | ||
| Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain | Q46338078 | ||
| Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size | Q46414402 | ||
| Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice | Q46535897 | ||
| Toxicity and tissue distribution of magnetic nanoparticles in mice. | Q46764075 | ||
| Particle size-dependent organ distribution of gold nanoparticles after intravenous administration | Q47249334 | ||
| Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging | Q47295130 | ||
| Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature | Q47374684 | ||
| Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. | Q48095451 | ||
| Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro | Q48096363 | ||
| Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles | Q48101628 | ||
| Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain | Q48111423 | ||
| The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study | Q48213433 | ||
| Nervous system effects in rats on subacute exposure by lead-containing nanoparticles via the airways. | Q48274610 | ||
| Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches | Q48402382 | ||
| Deposition of inhaled nanoparticles in the rat nasal passages: dose to the olfactory region | Q48433507 | ||
| The possible mechanism of silver nanoparticle impact on hippocampal synaptic plasticity and spatial cognition in rats. | Q48713651 | ||
| In vitro evidence of dysregulation of blood-brain barrier function after acute and repeated/long-term exposure to TiO(2) nanoparticles | Q48821111 | ||
| Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. | Q50518485 | ||
| Toxicity of manufactured zinc oxide nanoparticles in the nematode Caenorhabditis elegans. | Q50604073 | ||
| Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. | Q50668795 | ||
| Human amniotic membrane-derived mesenchymal stem cells labeled with superparamagnetic iron oxide nanoparticles: the effect on neuron-like differentiation in vitro. | Q50679496 | ||
| Experimental Investigations on the Penetration of198Au from Nasal Mucous Membrane into Cerebrospinal Fluid | Q51142966 | ||
| Isotherm modeling of organic activated bentonite and humic acid polymer used as mycotoxin adsorbents. | Q51546876 | ||
| Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. | Q51608572 | ||
| Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. | Q51771964 | ||
| Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. | Q51822443 | ||
| Ultracytochemical characterization of anionic sites in the wall of brain capillaries. | Q52065325 | ||
| Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. | Q52720014 | ||
| Hydrophilic/hydrophobic features of TiO2 nanoparticles as a function of crystal phase, surface area and coating, in relation to their potential toxicity in peripheral nervous system. | Q53182681 | ||
| Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. | Q53299281 | ||
| Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. | Q53421447 | ||
| Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. | Q53607271 | ||
| Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. | Q54718752 | ||
| Accurate localization of a fall in pH within the ileocecal region: validation using a dual-scintigraphic technique | Q57123656 | ||
| Skin | Q57432953 | ||
| Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide | Q58035159 | ||
| Glial Neurobiology | Q58456374 | ||
| Multicompartment and multigeometry nanoparticle assembly | Q58875038 | ||
| Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain | Q22337408 | ||
| Understanding biophysicochemical interactions at the nano-bio interface | Q23909863 | ||
| Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles | Q24536032 | ||
| Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways | Q24564031 | ||
| Subchronic inhalation toxicity of gold nanoparticles | Q24602007 | ||
| Renal clearance of quantum dots | Q24657265 | ||
| Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy | Q27004205 | ||
| Excess of neurons in the human newborn mediodorsal thalamus compared with that of the adult | Q28282949 | ||
| Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons | Q28384797 | ||
| Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomaterial | Q28387248 | ||
| Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation | Q28393643 | ||
| Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster | Q28478708 | ||
| What the Cell “Sees” in Bionanoscience | Q28651814 | ||
| The potential risks of nanomaterials: a review carried out for ECETOC | Q28767397 | ||
| Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles | Q29029891 | ||
| Regulated portals of entry into the cell | Q29547391 | ||
| Translocation of Inhaled Ultrafine Particles to the Brain | Q29547870 | ||
| Translocation of inhaled ultrafine manganese oxide particles to the central nervous system | Q29615577 | ||
| Interaction of gold nanoparticles with common human blood proteins. | Q30383615 | ||
| Evolution of increased glia-neuron ratios in the human frontal cortex | Q30477953 | ||
| Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain | Q30479578 | ||
| One at a time, live tracking of NGF axonal transport using quantum dots | Q30479997 | ||
| Antineoplastic activities of protein-conjugated silver sulfide nano-crystals with different shapes | Q30882149 | ||
| Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability | Q30993376 | ||
| Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro | Q33305954 | ||
| Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles | Q33377703 | ||
| Anti-proliferative activity of silver nanoparticles | Q33504392 | ||
| Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells | Q33659863 | ||
| Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles | Q33666994 | ||
| Behavioral effects of titanium dioxide nanoparticles on larval zebrafish (Danio rerio). | Q33897506 | ||
| Assessment of the In Vivo Toxicity of Gold Nanoparticles | Q33948983 | ||
| Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy | Q33956666 | ||
| Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors | Q37967666 | ||
| Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal | Q38976807 | ||
| Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles | Q39391621 | ||
| Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines | Q39456119 | ||
| Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. | Q39510403 | ||
| Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. | Q39521459 | ||
| Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines. | Q39633304 | ||
| Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells | Q39635839 | ||
| EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma | Q39677767 | ||
| Lipopolysaccharide-QD micelles induce marked induction of TLR2 and lipid droplet accumulation in olfactory bulb microglia | Q39705335 | ||
| Microglial response to gold nanoparticles. | Q39724343 | ||
| Nanoparticles can cause DNA damage across a cellular barrier | Q39778499 | ||
| Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse | Q39778619 | ||
| Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles | Q39787205 | ||
| Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles | Q39820364 | ||
| Nanosized zinc oxide particles induce neural stem cell apoptosis | Q39855879 | ||
| Sciatic nerve repair by microgrooved nerve conduits made of chitosan-gold nanocomposites | Q39987741 | ||
| Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models | Q40062045 | ||
| Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. | Q40091435 | ||
| Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. | Q40139914 | ||
| CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals | Q40218492 | ||
| Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. | Q40244635 | ||
| Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. | Q40373633 | ||
| Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. | Q40462539 | ||
| Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium | Q40824854 | ||
| Alternating Magnetic Field Controlled, Multifunctional Nano-Reservoirs: Intracellular Uptake and Improved Biocompatibility. | Q41564104 | ||
| Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature | Q41830204 | ||
| Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 | ||
| Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons | Q42625958 | ||
| Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats | Q42720973 | ||
| Toxicity of silver nanoparticles in zebrafish models | Q42727979 | ||
| Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes. | Q42742067 | ||
| Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain | Q33982602 | ||
| Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections | Q34142328 | ||
| Magnetic nanoparticles in primary neural cell cultures are mainly taken up by microglia | Q34206937 | ||
| Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals | Q34245733 | ||
| Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity | Q34280319 | ||
| Noninvasive imaging of quantum dots in mice | Q34291094 | ||
| Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. | Q34537954 | ||
| Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro | Q34556864 | ||
| Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery | Q34564681 | ||
| In vivo observation of gold nanoparticles in the central nervous system of Blaberus discoidalis | Q34633399 | ||
| Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration | Q34634591 | ||
| Gold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus | Q35093276 | ||
| Regulation and Modulation of pH in the Brain | Q35541864 | ||
| The role of environmental exposures in neurodegeneration and neurodegenerative diseases | Q35551001 | ||
| Drug resistance and cellular adaptation to tumor acidic pH microenvironment | Q35592647 | ||
| Nanotechnology and nanotoxicology in retinopathy | Q35600266 | ||
| Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. | Q35703091 | ||
| Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses | Q35839552 | ||
| Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology | Q36889441 | ||
| What do we (need to) know about the kinetic properties of nanoparticles in the body? | Q36942217 | ||
| Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels. | Q37149169 | ||
| Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots | Q37167336 | ||
| Colloidal metallic gold is not bio-inert | Q37181030 | ||
| Biological applications of gold nanoparticles | Q37258280 | ||
| Lymphatic drainage of the brain and the pathophysiology of neurological disease | Q37323411 | ||
| Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? | Q37334865 | ||
| Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies | Q37361729 | ||
| Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. | Q37461951 | ||
| Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. | Q37609944 | ||
| Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots | Q37668250 | ||
| Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies | Q37809976 | ||
| Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. | Q37817875 | ||
| Nanoparticles and colloids as contributing factors in neurodegenerative disease | Q37903240 | ||
| Gold revolution--gold nanoparticles for modern medicine and surgery | Q37903811 | ||
| P433 | issue | 4 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 346-373 | |
| P577 | publication date | 2013-04-08 | |
| P1433 | published in | Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | Q24056192 |
| P1476 | title | Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism | |
| P478 | volume | 5 |
| Q28084729 | Central nervous system toxicity of metallic nanoparticles |
| Q42798345 | Development of wheat glutenin nanoparticles and their biodistribution in mice |
| Q57340615 | In VivoNanotoxicity Assays in Animal Models |
| Q28394343 | Interactions between nanosized materials and the brain |
| Q57169956 | Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management |
| Q38504283 | Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles |
| Q28540929 | Tracking of magnetite labeled nanoparticles in the rat brain using MRI |
| Q30430371 | Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system |
Search more.